# A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System

> **NCT02370303** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 23 (actual)

## Conditions studied

- Lung Cancer
- Lung Neoplasms
- Cancer of Lung
- Cancer of the Lung
- Neoplasms, Lung
- Neoplasms, Pulmonary
- Pulmonary Cancer
- Pulmonary Neoplasms
- Carcinoma, Non-small-cell Lung
- Adenocarcinoma
- Squamous Cell Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02370303
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2016-07-09
- **Final completion:** 2016-07-09
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2018-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02370303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02370303, "A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02370303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*